Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0016382 (
flushing
)
6,387
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
A simple method with poliovirus as the model was developed for recovering human enteric viruses from aerosols. Filterite filters (pore size, 0.45 micron; Filterite Corp., Timonium, Md.) moistened with glycine buffer (pH 3.5) were used for adsorbing the aerosolized virus. No virus passed the filter, even with air flow rates of 100 liters/min. Virus recovery from the filter was achieved by rapid elution with 800 ml of glycine buffer, pH 10. The virus in the primary eluate was reconcentrated by adjusting the pH to 3.5, adding
AlCl3
to 0.0005 M, collecting the virus on a 0.25-micron-pore Filerite disk (diameter, 25 mm) and and eluting with 6 ml of buffer, pH 10. With this method, virus could be detected regularly in aerosols produced by
flushing
when 3 X 10(8) PFU of poliovirus were present in the toilet bowl. Poliovirus-containing fecal material from two of four infants who had recently received oral polio vaccine also yielded virus in the aerosols when feces containing 2.4 X 10(7) to 4.5 X 10(7) PFU of virus had been added to the toilet bowl. Persons infected with a variety of natural enteric viruses are known to excrete this amount of virus in their daily stools.
...
PMID:Method for detecting viruses in aerosols. 300 29
The combined processes of powdered activated carbon/biological powdered activated carbon- ultrafiltration (
PAC
/BPAC-UF) were used to treat secondary effluent. In this study, the effect of
PAC
and BPAC on membrane flux, membrane resistance and the removal of different molecular weight organic compounds were investigated. In addition, the structure characteristics of the microorganisms of the BPAC were analyzed. The results showed that the optimum dosage of
PAC
and BPAC was 10 mg/L and 40 mg/L respectively. The reversible membrane fouling resistance of BPAC-UF was higher than that of
PAC
-UF, and the two processes had the least irreversible resistance at the best dosage. The biodegradation of BPAC increased the concentration of small molecular weight organic matter up to 10,000 Da in the membrane effluent. So the dissolved organic carbon (DOC) removal effect of BPAC-UF process worsened. Microorganisms such as Proteobacteria, Bacteroidetes, Planctomycetes and other microorganisms on the surface of the BPAC enhanced the removal of organic matter in water. The results of scanning electron microscopy (SEM) scans showed that there was net mucus membrane on the UF membrane surface before the backwashing of the BPAC-UF process which increased the proportion of reversible pollution resistance. The physical
flushing
effect of BPAC-UF was better than that of direct UF and
PAC
-UF processes.
...
PMID:The membrane fouling mechanisms of the PAC/BPAC-UF combined process used to treat the secondary effluent from municipal wastewater treatment plant. 2933 20
Infusion of pituitary adenylate cyclase activating peptide-38 (PACAP-38) provokes migraine attacks in migraineurs and headache in non-migraineurs. Adverse events like long-lasting
flushing
and heat sensation can be terminated with oral antihistamine treatment, indicating the involvement of mast cell activation after PACAP-infusion. Degranulation of rat peritoneal mast cells was provoked by several isoforms of PACAP
via
previously unknown receptor pharmacology. The effect might thus be mediated either
via
specific splice variants of the
PAC
1
-receptor or
via
an unknown receptor for PACAP-38. In the present study, we characterize degranulation of rat meningeal mast cells in response to PACAP-receptor ligands. Furthermore, we investigate if PACAP-38-induced mast cell degranulation is mediated
via
PAC
1
-receptor splice variants and/or
via
the orphan Mas-related G-protein coupled member B3 (MrgB
3
)-receptor. To address this, the pharmacological effect of different PACAP isoforms on meningeal mast cell degranulation was investigated in the hemisected skull model after toluidine blue staining followed by microscopic quantification. Presence of mRNA encoding
PAC
1
-receptor splice variants and the MrgB
3
-receptor in rat mast cells was investigated by Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR) analysis. The effect of PACAP isoforms on
PAC
1
- and MrgB
3
-receptor-expressing
Xenopus laevis
oocytes were performed by two-electrode voltage-clamp (TEVC) electrophysiology. PACAP-38 is a more potent mast cell degranulating agent than Pituitary Adenylate Cyclase Activating Peptide-27 (PACAP-27) in the meninges. Presence of mRNA encoding the
PAC
1
-receptor and its different splice variants could not be detected in peritoneal mast cells by RT-PCR, whereas the orphan MrgB
3
-receptor, recently suggested to be a mediator of basic secretagogues-induced mast cell degranulation, was widely present. In
PAC
1
-receptor-expressing
Xenopus laevis
oocytes both PACAP-38, PACAP-27 and the specific
PAC
1
-receptor agonist maxadilan were equipotent, however, only PACAP-38 showed a significant degranulatory effect on mast cells. We confirmed Pituitary Adenylate Cyclase Activating Peptide(6-38) [PACAP(6-38)] to be a
PAC
1
-receptor antagonist, and we demonstrated that it is a potent mast cell degranulator and have an agonistic effect on MrgB
3
-receptors expressed in oocytes. The present study provides evidence that PACAP-induced mast cell degranulation in rat is mediated through a putative new PACAP-receptor with the order of potency being: PACAP-38 = PACAP(6-38) > > PACAP-27 = maxadilan. The results suggest that the observed responses are mediated
via
the orphan MrgB
3
-receptor.
...
PMID:PACAP-38 and PACAP(6-38) Degranulate Rat Meningeal Mast Cells
via
the Orphan MrgB
3
-Receptor. 3098 73